A monomeric, truncated form of the HA 1 subunit of the haemagglutinin of fowl plague virus can be isolated from chorioallantoic membranes of infected eggs. This type of soluble HA~ seems to be generated by the elimination of the amino-terminal 19 amino acids from the native HAx, including the disulphide linkage to the HA 2 subunit. The same type of truncated HA 1 could be isolated from a filtrate of the allantoic fluid of infected embryonated eggs. Antibodies prepared against this monomeric soluble form of HA 1 did not inhibit haemagglutination or neutralize viral infectivity, but interfered with virus release and would be expected to impair the spread of virus after infection.
Chorioallantoic membranes (CAM) from eggs infected with influenza viruses have been exploited as an ample source of viral nucleoprotein (NP) which was recovered from the soluble fraction by immunoaffinity chromatography (Becht & Malole, 1975; Stitz et al., 1990) . In the course of these experiments an extract from the membrane fraction of CAM homogenates was passed through an immunosorbent coated with the gamma globulin fraction of convalescent serum. When the eluate was assayed for the presence of viral haemagglutinin (HA) by agar gel diffusion, reactions were obtained with HA 1-specific antibodies but not with an antiserum directed against the HA 2 subunit of the viral HA. The isolation and description of some characteristics of this HAaspecific material are the object of this communication.
HA~ was isolated using immunoaffinity chromatography as previously described (Becht & Malole, 1975) . Sepharose CL-6B (Pharmacia) that had been pretreated with phloroglucinol and epichlorohydrin (Axen & Ernback, 1971; Porath & Sundberg, 1972) was activated with cyanogen bromide and conjugated with antibodies from the yolk of eggs from hens that had been immunized with fowl plague virus (FPV) (A/FPV/Rostock/34; H7N1). The globulin fraction isolated according to Jensenius et al. (1981) had a haemagglutination inhibition (HI) titre of 1/256.
Alternatively, monoclonal anti-HAa antibodies (MAbs) were conjugated to the activated Sepharose. For the preparation of MAbs BALB/c mice were immunized intraperitoneally with FPV glycoproteins which had been dissociated from purified egg-grown virus with 1-2 % n-octyl glucoside and mixed with an equal amount of aluminium hydroxide. Spleen cells were fused to SP2/0 cells according to standard procedures (Fazekas de St. Groth & Scheidegger, 1980; Lane, 1985) . Hybridomas secreting HAl-specific antibodies were screened by ELISA and HI. HA2-specific MAbs were prepared by immunizing mice with HA 2 which had been prepared by PAGE and eluted from the gel by electrophoresis. MAbs produced in Iscove's modified Dulbecco's medium containing 10 % horse serum were affinity-purified on an immunosorbent coated with anti-mouse immunoglobulin from egg yolk.
For coating an absorbent with HAl-specific antibodies four MAbs were pooled; two had HI titres of 1/1024, and two inhibited haemagglutination only marginally at dilutions of 1/8. Interestingly, one of the MAbs exhibiting high HI activity recognized a sequencedependent epitope, since it could be used as a reliable HAl-specific reagent in immunoblots; in contrast to the HA2-specific MAb this HAl-specific reagent was not bound by uncleaved HA.
HAl-reactive antigen was isolated from the membrane fraction of CAM from eggs infected with FPV. Washed CAMs that had been stored frozen were homogenized, crude membrane particles were removed by centrifugation for 30 min at 3000 r.p.m. ; the microsomal fraction was recovered from the supernatant by centrifugation at 35000r.p.m. for 1 h. The pellets were homogenized again as a roughly 10 % suspension in PBS, Triton X-100 and deoxycholate were added to final concentrations of 2% and 0.5% respectively, and the suspension was stirred for 30 min at room temperature. Insoluble particles were removed by centrifugation at 35000 r.p.m. for 1 h. The supernatant was diluted about 1 : 5 with PBS and passed through the affinity column which was washed with PBS containing 0"1% Triton X-100 and thereafter with PBS. Bound antigen was dissociated with 0.15 M-ethanolamine-HC1, 0.1 M-NaC1, pH 11.2. The eluate was neutralized immediately with HC1 by autotitration, dialysed against 0.01 M-Tris-HC1 pH 7"3, and applied to a column of Red A (Amicon) equilibrated with the same buffer. NP which had been bound by the immunosorbent containing convalescent antibodies passed through the Red A, and HA-specific material retained on the Red A column was eluted by 0-5 M-KCI in the starting buffer. Use of an immunosorbent coated with HAl-specific MAbs avoided the Red A purification step. When the eluate was examined with antibodies directed against the HA 1 and the HA 2 subunits of the FPV HA by agar gel precipitation only reactions with HAl-specific antibodies could be detected, whereas HA 2-specific antibodies did not produce precipitates. In immunoblots a virus-specific band could regularly be detected using HAl-specific MAbs, whereas only erratic and faint reactions appeared after probing with HA2-specific MAbs. In gels stained with Coomassie blue this HA 1 band was usually accompanied by several components of various sizes and staining intensities.
These contaminants could be eliminated from the eluates by isolectric focusing in a preparative flat-bed gel system (Pharmacia-LKB). The gel slurry of Sephadex IEF (Pharmacia) contained 3.2 ml of ampholine pH 4 to 9 and 1"8 ml of ampholine pH 9 to 11 per 100 ml total volume (Servalyt T 4-9 and T 9-11; Serva). The sample which had been dialysed against distilled water and supplemented with 6 N-urea was applied to the anodic half of the gel bed and run at 8 W for 18 h on a plate cooled at 10 °C. After elution of the samples with distilled water the presence of HA-specific reactivity was monitored by immunoblotting with the monoclonal HAl-specific antibody. HAl-specific reactivity could be recovered in fractions with an isoelectric point (IP) of approximately 8.9. These samples proved to be purified to homogeneity; they appeared in polyacrylamide gels as one band (Fig. 1 ) which could be identified as HAlspecific by immunoblotting (Fig. 2a) . The exclusive concentration of this component at an IP of 8.9 is underlined by the absence of contaminants even after extreme loading of the gel (Fig. 1, lane 2) . According to the migration rate in the gel this CAM-derived HA t (cHA1) must be slightly smaller (about 2K) than the virion-associated HA v Carbohydrate-specific staining in this position showed that the component is glycosylated (Fig. 1, lane 4) . In the purified preparations the absence of any trace of HA 2 could be substantiated by direct protein staining (Fig. 1) and immunoblotting (Fig. 2b) .
The deleted segment could be defined by sequencing the amino terminus of the purified HA1. After transfer of the polypeptide from the polyacrylamide gel onto an Immobilon-P membrane (Millipore) a strip encompassing the cHA 1 was cut out and used for automated 
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'---7 ----7 "--7 ---7 "--7--"7"--'7---7--'7---7-"7 sequencing of the 15 amino-terminal amino acids. About 80 pmol was sequenced on an Applied Biosystems pulsed liquid-phase sequencer, model 477 A, using the standard protocol recommended by the manufacturer (normal-1). Phenylthiohydantoin (PTH) derivatives of amino acids were identified by an on-line analyser, model 120 A (Applied Biosystems) with a repeated yield of 92 to 95 %.
In Fig. 3 (top) the sequence of the 15 amino-terminal amino acids has been aligned with the known amino acid sequence of the FP¥ HA1 chain (Porter et al., 1979) . It is evident from this figure that the N terminus of the isolated cHA~ starts with threonine at position 20 and continues in full correspondence with the known sequence. No PTH-amino acid appeared in position 28 which reflects the glycosylation of this Asn residue (Keil et al., 1984) .
The amino-terminal amino acid sequence showed that this soluble form of a truncated HA/, lacking 19 amino acids at the N terminus, is most likely formed by a second cleavage by a cellular protease between leucine in position 19 and threonine in position 20 (Fig. 3) . The deleted amino acids reflect the approximately 2K difference in M r estimated in polyacrylamide gels between the cell-derived and the virion-associated HA 1 (Fig. 1) . Such a secondary cleavage at this particular site would eliminate the disulphide link to the HA 2 moiety encompassing the hydrophobic regions and would liberate the HA 1 from the HA scaffold as proposed diagrammatically in Fig. 3 (bottom) . After this type of trimming, the cHA1 remains in solution as a monomer. This was shown in a gel permeation HPLC (M r range 2K to 80K; flow rate 0"8 ml/min) where the purified cHA1 co-migrated with ovalbumin. The high water solubility could explain the preferential isolation of this truncated HA from the membrane fraction of infected cells. Cleavage by a cellular protease, as proposed, resembles the effect of trypsin which produces HAl-specific polypeptides from the HA released from virus particles by bromelain treatment (Skehel et al., 1982) .
This type of cHA t might be the candidate for the binding site for HAl-specific antibodies which had previously demonstrated diffusely distributed antigens at the surface of the infected host cell outside the normal budding sites, where no HA2-specific antibodies were bound (Becht et al., 1984) . In a hydrophobicity profile, established according to Janin (1979) , three regions could be delineated within the cHAa polypeptide which are comparable to the signal peptide (amino acids 66 to 80; 182 to 193; 249 to 260) and which could possibly be inserted into the cell membrane and function as anchor sequences. Since these cHA~ molecules are not released from the membrane like the glycoproteins in budding sites, which are ultimately incorporated into the viral envelope, they would represent stable binding sites for antibody attack on the plasma membrane.
From the filtrate (pore exclusion > 300K) of the allantoic fluid after viral harvest an HAl-specific component could be isolated with immunosorbents coated with antibodies from convalescent sera or HA~-specific hybridomas by employing the same protocol as described above for the isolation of cHAv This antigen recovered from the allantoic fluid (sHA0 had the same IP as cHA 1, and HA 2 could not be detected in immunoblots prepared with the purified eluate (Fig. 2b, lane 3) . This secreted form of HA~ seems to have the same size as the cellassociated HA1 (Fig. 1) ; no substantial differences were noted in the staining reactions of immunoblots (Fig. 2a) or the carbohydrate detection kit (Fig. 1, lane 5) between cHA 1 and sHA r This sHAa isolated from the allantoic fluid can be considered as the naturally occurring analogue to the secreted form of FPV HA which has been found in the culture medium of cells that were transfected with a truncated HA gene that lacked the HA 2 coding sequence (Kretzschmar et al., 1992) in accordance with previous findings (Gething & Sambrook, 1982) . (a) (b) could enhance the vaccine. This antigen could therefore be of interest as an adjunct to neuraminidase in an 'infection-permissive immunization' protocol (Johannsen & Kilbourne, 1991) .
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We are obliged to K. G6bler and 3. Lowitzer for their excellent technical assistance. This work was supported by project 7-7/86, Federal Ministry of the Interior. The sHA1 secreted into the allantoic fluid was used to prepare an antiserum. After exhaustive absorption of antibodies against cellular antigens this rabbit serum did not inhibit haemagglutination and had no neutralizing activity. It did not cross-react in immunoblots with members of the H1, H2, H3 or H10 influenza A virus subtypes. However, when it was incorporated into the agar overlay of a plaque assay, these HAl-specific antibodies prevented the formation of plaques of normal size (Fig. 4) up to a dilution of 1/80. Essentially the same results were obtained with an anti-cHA1 serum. There was no interference with plaque formation when the antiserum-containing agar overlay covered a cell layer which had been infected with Newcastle disease virus, which excluded the possibility of a non-specific immobilizing effect on the cell membrane by residual anti-host antibodies (not shown).
The significance of the monomeric sHA 1 as an immunogen could reside in a stimulatory effect on the immune response after it is secreted into the environment of the infected cell. The resulting non-neutralizing anti-HA 1 antibodies would be expected to influence the course of the disease by interfering with virus release in a manner similar to that known for anti-neuraminidase antibodies (Seto & Rott, 1966; Schulman et al., 1968) and possibly for anti-M 2 antibodies (Zebedee & Lamb, 1988) . The mechanism underlying the prevention of virus release might be lattice formation by antibody between budding sites and cHA~ exposed at the cell surface, which could immobilize the cell membrane in a way similar to the effect exerted by bivalent lectins (Stitz et al., 1977) .
Since the soluble form of the HA1 described here can be expressed in conventional in vitro vectors, one could incorporate this material into influenza virus vaccines where the principle of interference with virus release
